Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies

Figures & data

Table 1 Patient demographics (N = 49)

Age (years)
Mean ± SD	56.57 ± 15.62
Range	26–85
Gender (%)
Male	26%
Female	74%
Race (%)
White	51%
Black	12%
Asian	8%
Hawaiian	4%
Hispanic	24%

Note: Age information was not available in 1 patient; gender information was not available for 2 patients.

Figure 1 Patient perceptions of itching and redness (PACE study).

Figure 2 Patient perceptions of tearing and swelling (PACE study).

Figure 3 Patient satisfaction (PACE study).

Figure 4 Patient drop comfort (CAC study).